European Case Law Identifier: | ECLI:EP:BA:2017:T213216.20170912 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 12 September 2017 | ||||||||
Case number: | T 2132/16 | ||||||||
Application number: | 08776043.5 | ||||||||
IPC class: | G06F 19/00 C12Q 1/68 |
||||||||
Language of proceedings: | EN | ||||||||
Distribution: | D | ||||||||
Download and more information: |
|
||||||||
Title of application: | DIAGNOSING FETAL CHROMOSOMAL ANEUPLOIDY USING GENOMIC SEQUENCING | ||||||||
Applicant name: | The Chinese University of Hong Kong | ||||||||
Opponent name: | OLSWANG LLP Polz, Leo Premaitha Health PLC |
||||||||
Board: | 3.3.08 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Late filed evidence - not admitted Added matter - (no) Clarity and sufficiency of disclosure - (yes) Priority - (no) Inventive step - (yes) |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t162132eu1.html
Date retrieved: 17 May 2021